Florida Gastroenterological Society
Florida Gastroenterological Society
Monthly Archives: May 2020

HER2-targeted therapy shows antitumor activity in metastatic colorectal cancer

Trastuzumab deruxtecan demonstrated durable benefit among patients with HER2-expressing metastatic colorectal cancer, according to findings of the phase 2 DESTINY-CRC01READ MORE ›

Posted in News

HER2-targeted therapy shows antitumor activity in metastatic colorectal cancer

Trastuzumab deruxtecan demonstrated durable benefit among patients with HER2-expressing metastatic colorectal cancer, according to findings of the phase 2 DESTINY-CRC01READ MORE ›

Posted in News

AGA announces awardees to receive research funding

The American Gastroenterological Association announced the 17 researchers who will receive funding through the AGA Research Foundation Awards program, accordingREAD MORE ›

Posted in News

AGA announces awardees to receive research funding

The American Gastroenterological Association announced the 17 researchers who will receive funding through the AGA Research Foundation Awards program, accordingREAD MORE ›

Posted in News

Dietary gluten does not increase Crohn’s, UC in women without celiac disease

No correlation was seen between dietary gluten intake and the risk for incidence Crohn’s disease or ulcerative colitis among womenREAD MORE ›

Posted in News

Dietary gluten does not increase Crohn’s, UC in women without celiac disease

No correlation was seen between dietary gluten intake and the risk for incidence Crohn’s disease or ulcerative colitis among womenREAD MORE ›

Posted in News

PAMORAs help achieve response in opioid-induced constipation

Peripherally acting mu-opioid receptor antagonists helped patients with opioid-induced constipation achieve therapeutic response, according to a meta-analysis published in AlimentaryREAD MORE ›

Posted in News

PAMORAs help achieve response in opioid-induced constipation

Peripherally acting mu-opioid receptor antagonists helped patients with opioid-induced constipation achieve therapeutic response, according to a meta-analysis published in AlimentaryREAD MORE ›

Posted in News

Pembrolizumab doubles PFS for certain patients with metastatic colorectal cancer

First-line pembrolizumab extended PFS vs. chemotherapy for patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer, according to findings to beREAD MORE ›

Posted in News

Pembrolizumab doubles PFS for certain patients with metastatic colorectal cancer

First-line pembrolizumab extended PFS vs. chemotherapy for patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer, according to findings to beREAD MORE ›

Posted in News

FGS Login Portal

[oasis_login]